Aim of the call
Proposals should cover topics such as understanding the molecular mechanisms underlying tumor initiation and progression, resistance, and metastasis; identifying novel biomarkers for early detection; and developing innovative treatment strategies including identifying and characterizing novel targets. Proposals should aim to drive disruptive research, with the goal of advancing the field of gastric and esophageal cancer research and ultimately improving patient outcomes.
Funding
-
Applicants may request funding to support a total budget up to $250,000 for a period of up to 12 months.
-
The budget and duration requested for the grant must match a realistic estimate of the cost and timeline for the proposed work.
-
The budget limit includes both direct and indirect costs, with indirect costs not to exceed 10% of the direct costs.
Eligibility
-
Applicants must be employed by a non-profit academic institution. Applications will be accepted from both U.S. and non-U.S. entities.
-
Researchers are limited to one application as principal investigator but may be co-investigators on other proposals without limitation.
-
Principal investigators must be independent researchers at their respective institutions
-
We encourage interdisciplinary collaborations and welcome proposals from independent investigators at all career stages, especially those new to the field of upper GI cancers. To facilitate this, preclinical resources (cell lines, organoids, and mouse models) will be made available to researchers who request them (see below for details)
Webinar
There will be a live webinar describing the application process and award that will take place on May 1st, 2024 at 12 pm Eastern Time, USA. Attendance is optional, and a recording of this will be posted for those unable to attend. Click here to register for the webinar.
Further Information
For more elaborate information, please visit the call page here.
Contact
Tlf: +1 646-866-5950
E-mai: INFO@THEMARKFOUNDATION.ORG